Canvas Medical, a San Francisco, CA-based EMR that enables clinicians and developers to power the future of care delivery, raised $24 million in Series B funding.
The round was led by M13 with participation from Haystack and previous investors Inspired Capital, IA Ventures, Upfront Ventures, and Irongrey.
With this funding, Canvas will continue to invest in bringing additional enterprise-grade capabilities to market, including security and governance features that put Canvas at the cutting-edge of extensibility and interoperability.
In addition to this funding, Canvas has achieved federal certification through the Office of the National Coordinator for Health Information Technology (ONC).
Company: Canvas Medical, Inc.
Raised: $24.0 M
Round: Series B
Funding Month: July 2022
Lead Investors: M13
Additional Investors: Haystack, Inspired Capital, IA Ventures, Upfront Ventures, and Irongrey
Company Website: https://www.canvasmedical.com/
Software Category: Healthcare Platform
About the Company: Founded in 2015, Canvas is reimagining the EMR for the future of healthcare. Canvas provides a full-stack ambulatory EMR and digital health developer platform, enabling both established and startup healthcare providers to launch new patient experiences and business models faster. Customers include care delivery companies like a mental health startup that uses Canvas to create custom clinical pathways, support telehealth scheduling, and charting, and drive care team collaboration with their patient app); and a primary care provider for adults 65+ that uses Canvas to embed clinical workflows into the point of care and enables patients to communicate with providers through Canvas’s APIs. Canvas’s suite of products is highly customizable by developers, seamless for providers, and gives care delivery companies full control over their patient experience.